Superworth

Myomo profit margin MYO

Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.

Net margin, 12 months
−33.5%
Operating margin, 12 months
−27.1%
Net margin on a year earlier
−10.7 pts
Peer median
8.4%

Over the twelve months to Jun 30, 2026, Myomo kept −33.5% of its revenue as net profit, with an operating margin of −27.1% and a gross margin of 68.4%.

Five years earlier its net margin was −90.1%.

The median for 7 medical instruments and supplies stocks of a similar size is 8.4%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−38.1%−35.2%65.7%
FY2024−19.0%−19.1%71.2%
FY2023−42.3%−42.8%68.5%
FY2022−68.9%−68.7%65.8%
FY2021−74.9%−74.1%74.4%
FY2020n/an/a65.7%
FY2019n/an/a63.0%
FY2018n/an/a70.2%
FY2017n/an/a67.6%
FY2016n/an/a74.4%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−33.5%−10.7 pts−27.1%
Q1 FY26−36.7%−21.6 pts−34.1%
Q4 FY25−38.1%−19.1 pts−35.2%
Q3 FY25−28.9%+4.4 pts−28.5%
Q2 FY25−22.9%+21.9 pts−22.8%
Q1 FY25−15.0%+32.7 pts−15.1%
Q4 FY24−19.0%+23.3 pts−19.1%
Q3 FY24−33.2%+9.2 pts−33.3%
Q2 FY24−44.7%+5.0 pts−44.8%
Q1 FY24−47.8%+21.9 pts−48.3%
Q4 FY23−42.3%+26.6 pts−42.8%
Q3 FY23−42.4%+30.2 pts−43.3%

Against its peers

Companies in Medical - Instruments & Supplies nearest Myomo's size, closest first, today.

CompanyProfit margin
MYOMyomo−33.5%
APTAlpha Pro Tech6.8%
NEPHNephros8.4%
KEQUKewaunee Scientific3.0%
PDEXPro DEX17.6%
UTMDUtah Medical Products29.0%
INFUInfuSystem6.0%
EMBCEmbecta8.6%
Peer median8.4%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Myomo

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.